share_log

HC Wainwright & Co. Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $390

HC Wainwright & Co. Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $390

HC Wainwright & Co.维持对Madrigal制药的买入,将目标股价下调至390美元
Benzinga ·  05/08 15:32

HC Wainwright & Co. analyst Ed Arce maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and lowers the price target from $425 to $390.

HC Wainwright & Co. 分析师埃德·阿尔塞维持Madrigal Pharmicals(纳斯达克股票代码:MDGL)的买入并将目标股价从425美元下调至390美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发